Guines LLC

Guines LLC (10% owner) buys 447,714 shares across 2 transactions totaling $1,461,372.93 at blended avg $3.26, raising stake 10.7% to 4.62M shares

Guines LLC, a 10% owner of BTMD, executed two separate purchases totaling 447,714 shares for $1,461,372.93 on May 6–7, 2025, at a blended average price of $3.26. This represents a 10.7% increase in the filer's holdings from 4,175,034 to 4.62M shares. The current price of $3.74 is -55.3% from the 52-week high of $8.36, though it has risen 15.1% over the prior 30 days. Notably, Guines LLC has executed four other buys at BTMD within the prior three weeks (April 9, 16, 17, 21, and 30), establishing a pattern of repeated accumulation at this ticker. The company's fundamentals show revenue of $51.4M with net income of $10.7M (latest quarter) and a 6.4% annual revenue growth rate, but trading at a P/E of 31.17. While the cross-ticker track record shows a 6.2% average 30-day return on 13 prior buys, none of the five recent BTMD-specific purchases are yet measurable at the 90-day mark, so outcome validation at this ticker is unavailable.

Guines LLC (10% Owner) purchased 1,933 shares of BTMD at $3.30 on 2025-04-30, totaling $6,371.17; fifth buy in three weeks

Guines LLC, a 10% shareholder, executed its fifth open-market purchase of BTMD in as many days (2025-04-08 through 2025-04-30), acquiring 1,933 shares at $3.30 on the most recent date. The cumulative pattern indicates sustained buying at consistent price levels during a period when the stock has declined 31.6% over 90 days and trades 58.4% below its 52-week high of $8.36. Across the insider's broader open-market history spanning multiple tickers, prior buys averaged a +2.2% 30-day return; however, none of the five same-ticker purchases at BTMD have yet reached 90-day measurement windows to assess timing accuracy. The company fundamentals remain solid—$51.4M quarterly revenue, $10.7M net income, +6.4% annual growth, and a P/E of 29.00—providing context for the accumulation despite recent price weakness. The high frequency of purchases in a compressed timeframe warrants closer examination of market conditions and the insider's stated rationale.

10% owner Guines LLC bought 8,801 shares of BTMD at $3.27 on 2025-04-21; stock down 59.0% from 52-week high of $8.36

Guines LLC, a 10% owner, purchased 8,801 shares at $3.27 on 2025-04-21 as part of a cluster of five buys at BTMD executed between 2025-04-07 and 2025-04-21. The company's financial position shows stable fundamentals: $51.4M in quarterly revenue, $10.7M net income, and 6.4% annual revenue growth. However, the stock has deteriorated significantly, trading at $3.43 currently and down 59.0% from its 52-week high of $8.36, with a 30-day decline of 12.0%. The insider's cross-ticker track record shows 11 prior open-market buys with an average 30-day return of +2.2%, but outcomes at this specific ticker are not yet measurable given the transactions occurred in April 2025. The timing pattern across the same-ticker history shows none of 0 prior buys were well-timed at the 90-day mark, a neutral baseline, though the current five-trade sequence began while the stock was already under significant pressure.

10% owner Guines LLC buys 7,874 shares at $3.29 across 2 transactions as stock falls 60.5% from 52-week high.

Guines LLC, a 10% owner, executed 2 purchases totaling 7,874 shares for $25,906.27 at $3.29 on 2025-04-16 and 2025-04-17, increasing holdings to 4,164,300 shares. The transaction occurs amid sharp recent weakness: the stock has declined 60.5% from its 52-week high and is down 18.9% over the past 30 days and 41.5% over 90 days. However, this purchase is part of a much larger pattern at this ticker—Guines has executed 5 prior buys at BTMD on 2025-04-03, 2025-04-04, 2025-04-07, 2025-04-08, and 2025-04-09, all within the past two weeks. The company's fundamentals show $51.4M in latest quarterly revenue and $10.7M net income with 6.4% annual growth, supporting a P/E of 27.50. Investors should monitor whether this rapid accumulation during a period of significant stock depreciation reflects a contrarian assessment of value or merely dollar-cost averaging during a broader decline.

10% owner Guines LLC purchased 48,439 shares at $3.21 in 2 transactions on 2025-04-08 and 2025-04-09; stock -59.9% from 52-week high.

Guines LLC, holding 4,156,426 shares post-transaction, executed 2 separate open-market purchases totaling 48,439 shares for $155,387.69 at $3.21 per share on consecutive trading days. The purchases occurred while BTMD trades at $3.35 current price, down -59.9% from its 52-week high of $8.36 and -18.9% over the trailing 30 days. The insider has 5 prior buys at this ticker within the past month (2025-03-17 through 2025-04-07), all with outcomes not yet measurable. Fundamentally, the company reported $51.4M quarterly revenue with $10.7M net income and trades at a P/E of 27.92 on a $195.0M market cap. The timing and persistence of accumulation through a sharp price decline merits investor attention to whether this reflects confidence in a turnaround or merely routine rebalancing.

Guines LLC (10% Owner) bought 74,440 shares across 3 transactions at BTMD for $237,405.51 at blended $3.19, amid -23.7% 30-day and -45.1% 90-day price declines.

Guines LLC executed 3 separate purchases totaling 74,440 shares for $237,405.51 between April 3–7, with a blended average price of $3.19 per share. The stock has fallen -23.7% over the past 30 days and -45.1% over 90 days, trading at $3.25 against a 52-week high of $8.36 (-61.1% from peak). This acquisition increases the filer's holdings to 4,107,987 shares, a +1.8% net addition to pre-transaction holdings of 4,033,547 shares. The company reported $51.4M in quarterly revenue, $10.7M net income, +6.4% annual revenue growth, and a P/E of 27.08. Guines LLC's same-ticker trading record at BTMD shows 4 prior buy transactions in March 2025, all too recent to measure 90-day outcomes. The timing of these purchases during a sustained price decline merits observation of whether this accumulation reflects informed conviction or mechanical portfolio rebalancing unrelated to company fundamentals.

10% owner Guines LLC buys 106,000 shares of BTMD at $3.32; stock down -58.6% from 52-week high, now trading at $3.46

Guines LLC, a 10% owner of biote Corp., purchased 106,000 shares at $3.32 on 2025-03-31, bringing total holdings to 4,033,547 shares. This represents an accumulation during a period of significant weakness: the stock has declined -58.6% from its 52-week high of $8.36 and is down -18.4% over the past 30 days. The purchase comes on the heels of three prior buys at BTMD within the preceding two weeks (2025-03-13, -14, and -17), suggesting a pattern of repeated accumulation as the stock price has contracted. The company's fundamentals show modest growth (revenue $51.4M, net income $10.7M, +6.4% annual revenue growth) with a P/E of 28.83, which remains elevated relative to the current depressed valuation. Given the compressed price action and concentrated buying pattern by a significant shareholder, investors should track whether these purchases signal conviction in the underlying business or simply reflect opportunistic deployment at lower prices.

Guines LLC (10% owner) acquired 856,609 shares for $2,784,419.26 across 3 purchases; 4 other insiders also bought within 14 days

Guines LLC, a 10% owner, completed three separate purchases totaling 856,609 shares for $2,784,419.26 at an average price of $3.25 per share between March 13–17, 2025, expanding its holding from 3,070,938 to 3,927,547 shares (+27.9%). The stock currently trades at $4.00, down 52.2% from its 52-week high of $8.36 and down 12.7% over the past 30 days, reflecting recent weakness. Notably, this transaction is part of a cluster pattern—4 other insiders also purchased shares within the same 14-day window—suggesting a coordinated response among multiple officers or shareholders to current market conditions. The company's fundamentals remain stable (P/E 33.33, $51.4M quarterly revenue, $10.7M net income, 6.4% annual revenue growth), yet the clustering of insider accumulation during a period of significant stock depreciation warrants examination of management's private perspective on intrinsic value versus market price.